EGFR and lung cancer: This cellular plasticity has been reported as having high clinical impact because it is crucial for drug resistance development, e.g., in lung cancer patients treated with EGFR inhibitors [25], reacquiring pluripotency and become a cancer stem cell (CSC) [26], or maintaining metastatic ability of many types of cancer cells [27,28,29].